Diversified Healthcare Trust (DHC) Cost of Revenue (2024 - 2026)

Diversified Healthcare Trust (DHC) has reported Cost of Revenue for 3 consecutive years, with $66.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue fell 15.8% year-over-year to $66.7 million; the trailing twelve-month figure through Jun 2026 stood at $297.0 million (down 8.25% YoY), and the FY2025 full-year result was $318.1 million, changed 0.25% from the prior year.
• Cost of Revenue slipped to $66.7 million in Q2 2026 per DHC's latest filing, from $71.2 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $85.4 million in Q4 2024 and bottomed at $66.7 million in Q2 2026.
• Historically, Cost of Revenue has averaged $77.5 million across 3 years, with a median of $78.7 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Cost of Revenue grew 3.98% in 2025, then slipped 15.8% in 2026.
• Over 3 years, Cost of Revenue stood at $85.4 million in 2024, then retreated by 8.37% to $78.2 million in 2025, then fell by 14.7% to $66.7 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $66.7 million, $71.2 million, and $78.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.